2023 annual financial data
Biodexa Pharmaceuticals 2023 Net margin
Biodexa Pharmaceuticals 2023 net margin with verified reported values.
Direct answer
Net margin was -1,858.01%.
Operating income was -8,014,000 GBP and net income was -7,079,000 GBP.
Operating cash flow was -6,826,000 GBP.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 381,000 GBP
- Operating income
- -8,014,000 GBP
- Net income
- -7,079,000 GBP
- Operating cash flow
- -6,826,000 GBP
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Biodexa Pharmaceuticals financial years